CurrentEndo
Get Weekly

Topic · page 36 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,401–1,440 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    High‐intensity statin therapy is associated with reduced coronary inflammation on CT in patients with type 2 diabetes mellitus

    Cohort study

  2. Diabet Med

    The Diabetes Attitudes Wishes and Needs (DAWN)‐SMI study: A cross sectional comparison of the psychosocial impact of diabetes in adults with and without severe mental illness

    Cross-sectional study

  3. Cardiovasc Diabetol

    Association of circulating metabolites and polygenic risk score with incident type 2 diabetes: a prospective community-based cohort study

    Cohort study

  4. Diabetes Obes Metab

    Orforglipron, an oral non‐peptide glucagon‐like peptide‐1 receptor agonist, improves markers of β‐cell function and insulin sensitivity in type 2 diabetes

    Secondary analysis

  5. Diabetes Obes Metab

    Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP ‐4 inhibitors: A multicentre, phase 4 randomized controlled trial

    Randomized controlled trial

  6. Diabetes Res Clin Pract

    A qualitative study of healthcare provider perspectives on challenges and opportunities to improve diabetes self-management practices in rural Bangladesh

    Research article

  7. BMJ

    Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline

    Guideline or statement

  8. J Clin Endocrinol Metab

    Identification of Gut Microbiome Signatures and Metabolites Associated With Albuminuria in Type 2 Diabetes

    Cross-sectional study

  9. BMJ

    Medications for adults with type 2 diabetes: a living systematic review and network meta-analysis

    Meta-analysis

  10. Diabetes Care

    Plasma Metabolome, Long-term Body Weight Change, and Type 2 Diabetes in U.S. Individuals

    Cohort study

  11. Diabetes Obes Metab

    Adherence to app‐based dose guidance for once‐weekly insulin icodec in insulin‐naive individuals with type 2 diabetes: Post hoc analysis of ONWARDS 5

    Secondary analysis

  12. Diabetes Technol Ther

    Cost Analysis of the FreeStyle Libre Systems in People with Type 2 Diabetes Mellitus on Basal Insulin with Poor Glycemic Control: A Spanish Perspective

    Cohort study

  13. Cardiovasc Diabetol

    Association of triglyceride-glucose-related indices with all-cause and cause-specific mortality in individuals with prediabetesss

    Cohort study

  14. Diabetes Obes Metab

    Comparative analysis on renal and cardiovascular outcomes of antidiabetic treatment in chronic kidney disease patients—A systematic review and network meta‐analysis

    Meta-analysis

  15. Diabetes Res Clin Pract

    GLP-1 receptor agonists and risk of hepatocellular carcinoma and all-cause mortality in patients with MASLD and type 2 diabetes: a propensity score–matched population-based cohort study

    Cohort study

  16. Diabetes Res Clin Pract

    New-onset diabetes mellitus post COVID-19 infection: a systematic review and meta-analysis

    Meta-analysis

  17. Lancet Diabetes Endocrinol

    The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in Canada

    Cohort study

  18. Cardiovasc Diabetol

    Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions

    Cross-sectional study

  19. J Clin Endocrinol Metab

    Compartment-specific Metabolic Alterations to Insulin Reflect Adiposity-driven Variation and Predict Type 2 Diabetes

    Mechanistic study

  20. Diabetes Obes Metab

    Effectiveness of GLP ‐ 1RA according to different type 2 diabetes phenotypes: A retrospective study

    Cohort study

  21. Diabetes Obes Metab

    Ketosis and ketoacidosis in hospitalized patients receiving SGLT2 inhibitor therapy

    Cohort study

  22. Int J Obes (Lond)

    Evidence of ethnic variations in the relationships between routinely recorded clinical factors and T2D: a systematic review and meta-analysis

    Meta-analysis

  23. Diabetes Obes Metab

    Long‐term effectiveness of iGlarLixi treatment in people with type 2 diabetes in the United States: The soli‐durability 24‐month observational study

    Cohort study

  24. J Clin Endocrinol Metab

    Effect of Osteocalcin on Insulin Sensitivity, Insulin Secretion, and β-cell Compensation in Mexican Americans

    Cross-sectional study

  25. Diabetes Res Clin Pract

    First-year oral antidiabetic adherence and long-term complications in newly diagnosed type 2 diabetes

    Cohort study

  26. Diabet Med

    Total and excess bed‐days in people with diabetes in Australia

    Cohort study

  27. Diabetes Metab

    Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework

    Cohort study

  28. Diabetes Res Clin Pract

    Cardiovascular outcomes of patients with type 2 diabetes after myocardial infarction and the impact of diabetes duration: a nationwide registry study

    Cohort study

  29. BMJ Open Diabetes Res Care

    Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study

    Cohort study

  30. Diabetes Care

    Health and Economic Impact and Cost-effectiveness of Produce Prescriptions for Diabetes in 50 U.S. States: A Microsimulation Study

    Research article

  31. Cardiovasc Diabetol

    Glucose metabolism in heterozygous familial hypercholesterolemia with a founder effect and a high diabetes prevalence: a cross-sectional study

    Cross-sectional study

  32. Cardiovasc Diabetol

    Longitudinal study reveals plasma glycans associations with prediabetes/type 2 diabetes in KORA study

    Cohort study

  33. Cardiovasc Diabetol

    Biological aging and incident cardiovascular diseases in individuals with diabetes: insights from a large prospective cohort study

    Cohort study

  34. Diabetologia

    Ethnic differences in beta cell function and pancreatic fat in Black African and White European men across a spectrum of glucose tolerance

    Cross-sectional study

  35. Diabetes Obes Metab

    GLY ‐200, an oral pharmacologic duodenal exclusion drug, resulted in positive effects on glucose, lipids and bodyweight in patients with type 2 diabetes: Results of a randomized, double‐blind placebo‐controlled trial

    Randomized controlled trial

  36. Diabetes Obes Metab

    Combined GPR40 and GPR119 full agonism with K‐757 and K‐833 results in robust glucose lowering and modest weight loss in overweight/obese subjects with T2DM

    Randomized controlled trial

  37. Diabetes Res Clin Pract

    Adherence patterns to cardiovascular medications in people with type 2 diabetes mellitus: a retrospective cohort study using group-based trajectory analysis in primary care

    Cohort study

  38. BMJ

    Total and specific potato intake and risk of type 2 diabetes: results from three US cohort studies and a substitution meta-analysis of prospective cohorts

    Meta-analysis

  39. Diabetes Res Clin Pract

    Predicting factors of sleep quality among adults with type 2 diabetes mellitus: A systematic review

    Meta-analysis

  40. Diabetes Res Clin Pract

    Metabolomics-based prediction model for diabetes: A comprehensive analysis of biomarkers and machine learning approaches

    Cross-sectional study

All 4,758 Briefs in ExploreShowing Briefs 1,401–1,440 of 4,758, newest first